Viewing StudyNCT05212454



Ignite Creation Date: 2024-05-06 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 2:23 PM
Study NCT ID: NCT05212454
Status: RECRUITING
Last Update Posted: 2023-04-25
First Post: 2022-01-15

Brief Title: Efficacy of Supplement Adjuvant Capecitabine in HRHER2- Breast Cancer Patients With High Risks
Sponsor: Second Affiliated Hospital School of Medicine Zhejiang University
Organization: Second Affiliated Hospital School of Medicine Zhejiang University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-03-15
Start Date Type: ACTUAL
Primary Completion Date: 2025-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-12
Completion Date Type: ESTIMATED
First Submit Date: 2022-01-15
First Submit QC Date: January 15 2022
Study First Post Date: 2022-01-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-22
Last Update Post Date: 2023-04-25
Last Update Post Date Type: ACTUAL